Objective: The aims of this study were to verify the effects of photobiomodulation therapy (PBMT) on time trial run performance over 1500 m, as well as on individual responsiveness of recreative runners. Materials and methods: Nineteen recreationally trained runners participated in a randomized, crossover, double-blind placebo-controlled trial. The study was divided in four sessions: (1) incremental maximal running test; (2) 1500 m run control (without placebo or PBMT); and (3, 4) PBMT or placebo before 1500 m run. PBMT or placebo was applied over 14 sites per lower limb immediately before time trial run using a mixed wavelength device (33 diodes: 5 LASERs of 850 nm, 12 LEDs of 670 nm, 8 LEDs of 880 nm, and 8 LEDs with 950 nm). PBMT delivered 30 J per site, with a total energy dose of 840 J. Physiological variables [maximal oxygen uptake (VO2MAX), velocity associated to VO2MAX (vVO2MAX), peak of velocity, and respiratory compensation point (RCP)] were assessed during incremental maximal test. During 1500 m races we accessed the following: time, heart rate, and lower limb rate perception exertion per lap, total time, and blood lactate concentration ([Lac]). Results: PBMT had no significant difference and likely trivial effect for performance in the total time trial run over 1500 m compared to placebo. In the responsiveness analyses, 10 participants positively responded to PBMT, whereas total time reduced for responders (-10.6 sec; -3.18%) and increased for nonresponders (+6.0 sec; +1.73%). Responders presented higher aerobic parameters (VO2MAX and RCP) than nonresponders. Moreover, responders had lower time per lap and [Lac] (1 and 3 min) when PBMT was applied. Conclusions: PBMT applied immediately before running in noncontrolled environment was not able to improve the 1500 m performance of recreationally trained runners. However, responders to PBMT presented higher aerobic capacity than nonresponders.
Keywords: athletics; ergogenic aid; light-emitting diode therapy; low-level laser therapy; running performance.